Stratasys and Ricoh co-sponsor clinical study
comparing the efficacy of 3D printed models to traditional CT or
MRI scanning for bone tumor excision planning
Stratasys Ltd. (NASDAQ: SSYS) and Ricoh USA, Inc. today
announced the enrollment of the first patient in a groundbreaking
clinical study aimed to evaluate the use of 3D printed models for
orthopedic oncology. The study will assess the efficacy of
patient-specific 3D printed anatomical models for preoperative
planning and tumor excision in comparison to the current standard
of care, which relies solely on CT or MRI imaging.
The joint research aims to demonstrate potential improvements in
surgical outcomes, including reduced blood loss, shorter operating
time including time under anesthesia, and decreased risk of
procedural complications. To do this, clinical outcomes will be
compared between an experimental group in which tumors are excised
using 3D printed models alongside imaging for planning, and an
active comparator group in which tumor excision will be prepped
solely with imaging.
Benefits for medical staff and patients
The benefits of 3D printed models in preoperative planning are
severalfold and positively impact both medical practitioners and
patients alike. Doctors and surgeons benefit from improved and more
informed presurgical planning and practicing prior to operations,
making complex procedures more efficient, economical and faster.
Unlike the limitations of computer images, this enables doctors to
represent vital aspects of patient anatomy with life-size physical
replicas, granting them the means to simulate procedures and aid in
their precision of excision, ultimately reducing the chances of a
positive margin. In turn, the availability of accurate 3D printed
models to better communicate planned procedures, together with a
greatly improved surgical process, helps to improve patient outcome
and recovery.
The prospective, multi-center randomized controlled study is
expected to run for 12 months and involve up to 150 subjects across
three sites. The two sites which have agreed at this time to
participate are The Ohio State University Wexner Medical Center and
Corewell HealthTM, based in Michigan.
“Our never-ending mission is to improve patient outcomes, and
that starts with preoperative planning,” said Kyle K. VanKoevering,
MD Associate Professor, Otolaryngology - Head and Neck Surgery,
Ohio State Wexner Medical Center. “We look forward to participating
in this study to examine how 3D printed models may help the medical
staff better prepare for surgery as well as improve patient
education.”
“Being one of the sites to participate in this study puts us on
the forefront of demonstrating new technologies that can advance
patient care and improve health outcomes,” said Aws Hammad, M.D.,
clinical faculty of orthopaedic surgery at Corewell Health William
Beaumont University Hospital. “Addressing the challenges that come
along with bone sarcomas and utilizing the power of
patient-specific 3D modeling is a significant step in not only
patient education but as an aid to surgeons for more precise
surgical procedures.”
According to Erez Ben Zvi, VP Medical at Stratasys, “The
collaboration brings together unparalleled experience and
innovation in medical imaging and 3D printing and, if successful,
may establish anatomical models as a new standard for patient
treatment in tumor removal from bones.”
Gary Turner, Managing Director, Additive Manufacturing, Ricoh
USA, Inc., comments, “We are thrilled to co-sponsor this important
clinical trial alongside our longstanding partners at Stratasys to
further demonstrate the potential impact of 3D patient-specific
modeling as well as accelerate adoption of this technology to
better serve a broader population.”
About Ricoh
Ricoh is a leading provider of integrated digital services and
print and imaging solutions designed to support digital
transformation of workplaces, workspaces and optimize business
performance.
Headquartered in Tokyo, Ricoh's global operation reaches
customers in approximately 200 countries and regions, supported by
cultivated knowledge, technologies, and organizational capabilities
nurtured over its 85-year history. In the financial year ended
March 2024, Ricoh Group had worldwide sales of 2,348 billion yen
(approx. 15.0 billion USD).
It is Ricoh's mission and vision to empower individuals to find
Fulfillment through Work by understanding and transforming how
people work so we can unleash their potential and creativity to
realize a sustainable future.
For further information, please visit www.ricoh.com.
About Stratasys
Stratasys is leading the global shift to additive manufacturing
with innovative 3D printing solutions for industries such as
aerospace, automotive, consumer products and healthcare. Through
smart and connected 3D printers, polymer materials, a software
ecosystem, and parts on demand, Stratasys solutions deliver
competitive advantages at every stage in the product value chain.
The world’s leading organizations turn to Stratasys to transform
product design, bring agility to manufacturing and supply chains,
and improve patient care.
To learn more about Stratasys, visit www.stratasys.com, the
Stratasys blog, X/Twitter, LinkedIn, or Facebook. Stratasys
reserves the right to utilize any of the foregoing social media
platforms, including Stratasys’ websites, to share material,
non-public information pursuant to the SEC’s Regulation FD. To the
extent necessary and mandated by applicable law, Stratasys will
also include such information in its public disclosure filings.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240626817575/en/
Investor and Media
Contacts:
Stratasys Corporate & North America
Chris Reese Chris.Reese@stratasys.com +1 6651 357 0877
Europe, Middle East, & Africa Jonathan Wake /
Samantha White, Incus Media Stratasys@Incus-Media.com +44 1737
215200
Stratasys Corporate & Israel Erik Snider
Erik.Snider@stratasys.com +972 74 745 6053
Investor Relations Yonah Lloyd Yonah.Lloyd@stratasys.com
+972 74 745 4919
Brazil, Central America and South America Erica Massini
Erica.Massini@stratasys.com +55 (11) 2626-9229
Asia Kalyani Dwivedi Kalyani.Dwivedi@stratasys.com +91 80
6746 2606
Stratasys (NASDAQ:SSYS)
過去 株価チャート
から 5 2024 まで 6 2024
Stratasys (NASDAQ:SSYS)
過去 株価チャート
から 6 2023 まで 6 2024
